Secretariat Time Programme
Daily
12:00 - 13:30

sfe

Papadimitriou Evangelia PDF Print
Tel. : (+302610) 962336
Fax :
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

CV Papadimitriou

CURRENT FOCUS OF RESEARCH

  • Angiogenesis and tumor growth in vivo and in vitro. Pharmacological studies on the mechanisms involved, and evaluation of new compounds or nanoparticles for their anti-angiogenic and anti-tumor activity.
  • The biological actions of the heparin-binding growth factor pleiotrophin. Effects on endothelial cell functions, angiogenesis, tumor growth and metastasis, bone cell biology. Signaling and receptors identification. Structure-function studies.
  • The role of receptor RPTPbeta/zeta in angiogenesis and tumor growth. Structure-function studies.

PUBLICATIONS

International Journals with referees: 78
Greek Journals: 5
Books: 15
Cited conference abstracts: 95
Abstracts in conference proceedings: 67 (International Conferences), 85 (Greek Conferences)

CURRENT TEACHING ACTIVITIES

Undergraduate:

  • Pharmacology Ι and ΙΙ
  • Molecular Pharmacology
  • Introduction to Pharmaceutical Sciences

Postgraduate:

  • Molecular Targets of Drug Action
  • Drug Interactions – Toxicology
  • Molecular Pharmacology-Immunology (Department of Chemistry, University of Patras)
  • Structure and Function of Macromolecules – Pharmacology (MSc in Chemical Biology, Depts of Chemistry, Pharmacy and Medicine, University of Patras)

SELECTED PUBLICATIONS

  • Poimenidi E, Theodoropoulou C, Koutsioumpa M, Skondra L, Droggiti E, van den Broek M, Koolwijk P, Papadimitriou E. “Vascular endothelial growth factor A (VEGF-A) decreases expression and secretion of pleiotrophin in a VEGF receptor-independent manner”. Vasc Pharmacol, doi: 10.1016/j.vph.2016.02.008, 2016.
  • Koutsioumpa M, Poimenidi E, Pantazaka E, Theodoropoulou C, Skoura A, Megalooikonomou V, Kieffer N, Courty J, Mizumoto S, Sugahara K and Papadimitriou E. “Receptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factor”. Mol Cancer, 14: 19, 2015.
  • Pantazaka E. and Papadimitriou E. “Chondroitin Sulfate-cell membrane effectors as regulators of growth factor-mediated vascular and cancer cell migration”. BBA - General Subjects, 1840: 2643-2650, 2014.
  • Koutsioumpa M. and Papadimitriou E. “Cell surface nucleolin as a target for anti-cancer therapies”. Recent Pat Anticancer Drug Discov: 9: 137-152, 2014.
  • Papadimitriou E. “Pleiotrophin”. In: Encyclopedia of Cancer, doi: 10.1007/978-3-642-27841-9_4621-3. Editor: Manfred Schwab, Springer-Verlag Berlin Heidelberg, 2014.
  • Koutsioumpa M., Polytarchou C., Courty J., Zhang Y., Kieffer N., Mikelis C., Skandalis S., Hellman U., Iliopoulos D. and Papadimitriou E. “Interplay between alpha v beta 3 integrin and nucleolin regulates human endothelial and glioma cell migration”. J Biol. Chem., 288: 343-354, 2013.